1 / 76

Autoimmune polyglandular syndromes

Autoimmune polyglandular syndromes. Irene Fung PGY2 Endocrinology rounds January 30, 2009. Objectives. Overview of autoimmune endocrine disease To recognize the clinical presentation of APS-1 and APS-2 To understand work-up and management of primary adrenal insufficiency and hypothyroidism

aevelyn
Download Presentation

Autoimmune polyglandular syndromes

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Autoimmune polyglandular syndromes Irene Fung PGY2 Endocrinology rounds January 30, 2009

  2. Objectives • Overview of autoimmune endocrine disease • To recognize the clinical presentation of APS-1 and APS-2 • To understand work-up and management of primary adrenal insufficiency and hypothyroidism • To learn the underlying patho-physiology of APS-1 and APS-2

  3. Autoimmune disease and endocrinology • Hashimoto’s thyroiditis • Grave’s disease • Addison’s disease • Oophoritis • Hypoparathyroidism • Lymphocytic hypophysitis

  4. Autoimmune endocrine disease • Genetics component • Type I DM risk • Monogenic twins: ~50% • Siblings: 3-4% • General population: 0.3% • Polymorphisms in HLA DR and DQ

  5. Monogenic diseases • APS1 • Autoimmune polyglandular syndrome type 1 • IPEX • Immune dysregulation, polyendocrinopathy, enteropathy, X-linked

  6. Jimmy’s Story

  7. Jimmy: 18 months • 18 months, previously well child • Seizures, progressive frequency • Low calcium • Low PTH http://jimneydandme.wordpress.com/james-story/

  8. DDx: neonatal hypocalcemia w/ low PTH • Impaired synthesis or secretion • Genetic • DiGeorge Syndrome • HDR Syndrome (Hypoparathyroidism, deafness, renal anomaly) • Sanjad-Sakati syndrome • Mitochondrial disorders (eg. MELAS Syndrome) • Defect of the calcium sensing receptor • Infiltration of parathyroid gland (eg. iron overload) • Infection (eg. gram-negative sepsis, HIV) • Autoimmune polyglandular syndrome type 1 (APS1)

  9. Jimmy’s story – 6 yo • Recurrent infections • Otherwise healthy

  10. Jimmy’s story – 14 yo • Vomiting • Weight loss • Decreased appetite

  11. Review of Glucocorticoid Function • Metabolic • Circulatory and renal • Growth • Immunologic • Skin, Bone, and Calcium effects • CNS

  12. GCs: Metabolic Effect • ↑ hepatic GNG • ↑ hepatic glycogen production • ↑ cellular resistance to insulin • ↑ lipolysis • ↑ proteolysis (except in heart and diaphragm)

  13. GCs: Circulation & Renal • Positive ionotrope effect on heart • Permissive effect on Epi and Norepi

  14. GCs: Growth • Inhibit linear growth and skeletal maturation • Decrease GH and IGF-1 • Accelerate tissue development and differentiation

  15. GCs: Skin, Bone, Calcium • Inhibit fibroblasts • ↓GI absorption of Ca2+, • ↓renal absorption of Ca2+ and phosphorus • 2º↑ in PTH) • Risk of osteoporosis

  16. GCs: Immunologic • Block histamine and pro-inflammatory cytokines • Decrease chemotaxis and phagocytosis of PMNs • Decrease cellular immune response

  17. GCs: CNS effects • Stimulate appetite • Reduce REM sleep • ↑ sensitivity to serotonin receptors

  18. Review of Mineralocorticoid: Function • Maintain intravascular volume • Conserve Na+ • Eliminate K+ and H+

  19. Adrenal Insufficiency Clinical Presentation • Muscle weakness • Malaise • Anorexia • Vomiting • Weight loss Physical Exam • Orthostatic hypotension • Hyperpigmentation

  20. Adrenal insufficiency (AI) labs • Low BS • Ketosis • Anemia • High eosinophils, lymphocytes • High K+ , Low Na+

  21. Adrenal insufficiency (AI) labs • Stage 1: high renin, nr/low aldosterone • Stage 2: impaired cortisol response to cosyntropin • Stage 3: ↑ morning ACTH • Stage 4: Inappropriately low cortisol • ↑ urinary excretion of Na and Cl

  22. Autoimmune AI: antibodies • +adrenal Abs (92% PPV for AI devpt) • Stronger predictor of eventual AI in children vs adults • Other markers • Anti-CYP21A2 Ab • Anti-interferon Abs (esp. interferon –omega)

  23. Autoimmune AI: antibodies • Check for Abs against other endocrine glands • Anti TPO Ab • Gastric parietal cell Ab • Intrinsic factor (IF) Ab • Gonadal Ab • Anti-parathyroid gland Ab • Anti IA-2 tyrosine phosphatase-like protein, insulin

  24. AI presentation based on age Infants: • Can get ill very quickly • Decrease activity, anorexia, vomiting • High K, Low Na, Low BS • May not have ketosis

  25. AI presentation based on age Older Children • Muscle weakness • Malaise • Anorexia • Vomiting • Weight loss • May have salt craving • May have hyper-pigmentation • Orthostatic hypotension • Can be mistaken for gastroenteritis, acute infection

  26. Definitive testing for AI ACTH stimulation test • Baseline cortisol level • 0.25 mg cosyntropin (ACTH) • Cortisol at 30 min or 60 min after • In 1o AI: resting level is low and does not increase • In 2o AI: may show low resting level and significant response

  27. Acute Tx of AI • Low volume, Low Na+, Low BS: • D5NS • Hydrocortisone q6h x 4 doses • 25 mg for toddlers, 50 mg for child, 100 mg for adolescent • High K+: IV Ca gluconate, Kayexalate, IV glucose/insulin

  28. A word of caution: AI and hypothyroidism Providing thyroxine can increase cortisol clearance Adrenal crisis can be precipitated if hypothyroidism treated without first providing GC replacement!

  29. Chronic Tx of AI Hydrocortisone 10 mg/m2/daypo divided TID • ACTH used to monitor adequacy of GC replacement • Stress dose: increase dose by 2- or 3-fold

  30. Chronic Tx of AI Fludrocortisone (Florinef) 0.05-0.3 mg po OD • Renin to monitor adequate replacement

  31. Jimmy’s story – 16 yo • Polyuria • Polydipsia • Dx: Type I DM • Rx: Insulin

  32. Jimmy’s story – 18 yo • Alopecia • Vitiligo • Spooning nails • Pernicious anemia

  33. Jimmy’s story – 24 yo • Photophobia • Decreased visual acuity • Dx: Keratopathy

  34. Summary of Jimmy’s clinical diseases • Candidiasis • Hypoparathyroidism • Adrenal insufficency • Alopecia • Vitiligo • Pernicious anemia • Type I DM • Keratopathy

  35. Autoimmune Polyglandular Syndromes • Constellations of ≥ 2 endocrine gland insufficiencies as well as disorders of non-endocrine organs • Caused by an immune-mediated dysregulation of endocrine glands

  36. APS-1 • Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) • Rare, pockets of higher frequency in Finland, Iran, Sardania • Autosomal recessive

  37. APS-1 • 2 of 3 of: • Candidiasis • Hypoparathyroidism • Adrenal insufficiency • All 3 usually seen by 2nd decade

  38. J Clin Endo Metab 1998:83(4):1049-1055

  39. APS-1 • Other closely associated autoimmune disorders: • Gonadal failure (~60 %) • Intestinal malabsorption, chronic active hepatitis (~25%) • Hypothyroidism and type I diabetes mellitus occur in (~10%) • Alopecia, vitiligo, keratopathy, enamel hypoplasia, nail dystrophy

  40. APS-1 • Organ specific immunity (versus systemic)

  41. AIRE1 gene • several domains reminiscent of transcriptional regulators • 60 different mutations in the AIRE1 gene described

  42. AIRE gene • Encodes a 545 amino acid protein • Missense mutations clustered in 3 regions: • HSR region: dimerization • SAND domain: DNA binding • PHD domains: ?E3 ubiquitin ligase

  43. APS-1 genetics • AIRE expression in lymphoid organs, in particular the thymus • Expressed in medullary thymic epithelial cells (mTECS) as well as in dendritic cells

  44. AIRE • Aire knockout mouse: multi-organ autoimmunity (serum autoAbs, inflammatory infiltrates) • Transfer of thymic epithelial cell of Aire knockout into recipient led to autoimmunity

  45. AIRE regulates transcription of peripheral tissue antigens (PTAs)

  46. Nature Reviews Immunology 2007 7:645-650

  47. Nature Reviews Immunology 2007 7:645-650

  48. Molecular mechanisms How does AIRE control expression of a range of genes encoding proteins with divergent transcriptional regulation in their usual cellular locations? How is expression of AIRE controlled? Other proteins does AIRE partner with?

  49. Development • Does AIRE affect the differentiation of thymic medullary epithelial cells? If so, how? • Does AIRE influence the survival of MECs? If so, how? • During what age-window is AIRE important?

  50. Immunological issues • Additional role(s) of AIRE in clonal deletion of thymocytes? • Why are some peripheral organs attacked in the absence of AIRE and others not? • Why do patients with APS-1 almost universally develop candidiasis infections?

More Related